News

MACOM Sees Strong Growth in Fiscal Q2 Earnings Report

MACOM Sees Strong Growth in Fiscal Q2 Earnings Report

Overview of MACOM's Fiscal Second Quarter 2025 Results

In a bright report released recently, MACOM Technology Solutions Holdings, Inc. (Nasdaq: MTSI) has showcased its robust financial performance for the fiscal second quarter ending in April 2025. This reflects MACOM's commitment to innovation and growth within the semiconductor industry.

Key Financial Highlights

Fiscal Year 2025 GAAP Results:

  • Revenue reached $235.9 million, marking a remarkable 30.2% increase compared to $181.2 million during the same period last year and an 8.1% rise from the prior quarter's $218.1 million.
  • The gross margin was recorded at 55.2%, showing improvement from 52.5% in the previous year and 53.7% in the preceding quarter.
  • Income from operations reached $34.9 million, representing 14.8% of revenue, compared to an operational income of $15.4 million or 8.5% of revenue in the same quarter last year.
  • An impressive net income of $31.7 million translates to earnings of $0.42 per diluted share, which is a commendable increase from $15.0 million, or $0.20 per diluted share a year earlier.

Adjusted Non-GAAP Results

The adjusted financial metrics further underscore MACOM's thriving performance:

  • The adjusted gross margin stood at 57.5%, slightly higher than the 57.1% noted in the previous year’s quarter.
  • Adjusted income from operations was reported at $59.8 million, making up 25.4% of revenue, compared to $40.2 million, or 22.2% of revenue, in the same quarter last year.
  • Adjusted net income surged to $64.3 million, yielding $0.85 per diluted share, reflecting growth from $43.2 million, or $0.59 per diluted share, a year ago.

Management Insights

“The solid performance in Q2 is a testament to the exceptional teamwork throughout the MACOM organization,” stated Stephen G. Daly, President and Chief Executive Officer of MACOM. This reinforces the collaborative culture driving MACOM’s success in the competitive semiconductor arena.

Future Business Outlook

Looking to the upcoming fiscal third quarter, which concludes on July 4, 2025, MACOM anticipates revenue to be between $246 million and $254 million. The adjusted gross margin is projected to range between 56.5% and 58.5%, with adjusted earnings expected between $0.87 and $0.91 per diluted share, utilizing an expected non-GAAP income tax rate of 3% and approximately 76.5 million fully diluted shares outstanding.

About MACOM Technology Solutions

MACOM designs and produces top-tier semiconductor products tailored for industrial, defense, data center, and telecommunications sectors. With more than 6,000 customers worldwide, MACOM continues to innovate with a broad portfolio encompassing RF, microwave, analog, mixed-signal, and optical technologies. The company conforms to several international standards, including IATF16949 for automotive, AS9100D in aerospace, ISO9001 for global quality, and ISO14001 for environmental management, showcasing its dedication to quality and excellence in operations.

Frequently Asked Questions

What were MACOM's total revenues for the second quarter of fiscal year 2025?

MACOM reported total revenues of $235.9 million for the fiscal second quarter of 2025.

What is the projected revenue for the third quarter of fiscal year 2025?

For the third quarter, MACOM expects revenue to be in the range of $246 million to $254 million.

How much did MACOM's net income increase by compared to the previous year's quarter?

Net income rose to $31.7 million, a significant increase compared to $15.0 million in the prior year's quarter.

What was the percentage increase in MACOM's income from operations?

Income from operations increased from $15.4 million to $34.9 million, represented as a percentage of revenue.

Is MACOM planning any expansions or new product developments?

Although specifics are not detailed, MACOM's strong financial positioning suggests potential for expansion and new product innovations.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 266

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 208

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 33

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 0

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover How Indovinya's Innovations Boost Sustainable Agriculture

Updated Category News Views 93

Unlocking the Potential of Biopesticides in Agriculture Indovinya introduces innovative solutions to enhance the use of biologically based products amidst a growing drive for sustainable crop protection. Advancements in Biopesticide Utilization The adoption of biopesticides as an alternative to traditional agrochemicals is gaining traction. However, the integration of...

Continue Reading
SCHMID Group Expands Influence with New Equipment Orders

Updated Category News Views 155

SCHMID Group Strengthens Market Position with New Orders In an exciting development from the SCHMID Group, a key player in the equipment manufacturing sector, the company has recently secured significant orders for Panel Level Packaging (PLP) and modified Semi-Additive (mSAP) production equipment. The orders mark a noteworthy advance as SCHMID continues to bolster its...

Continue Reading
X4 Pharmaceuticals Completes Major Equity Financing and Leadership Shift

Updated Category News Views 178

Major Equity Financing by X4 Pharmaceuticals X4 Pharmaceuticals has made headlines recently with its announcement of a significant private equity financing round totaling $60 million. This funding is primarily geared towards advancing the company’s promising treatment for rare immune system diseases, demonstrating their commitment to improving patient outcomes. Leading...

Continue Reading
IGI Secures Fast Track from FDA for Promising Cancer Treatment

Updated Category News Views 124

IGI Receives Fast Track Designation for ISB 2001 Results from the dose-escalation portion of the Phase 1 clinical study of ISB 2001, an innovative treatment for heavily pretreated multiple myeloma patients, will be showcased at an upcoming major oncology conference. This exciting news highlights IGI's continued progress in developing groundbreaking therapies. About ISB...

Continue Reading
Prospera Energy Reports Strong Financial Performance for 2024

Updated Category News Views 163

Prospera Energy's Transformative Year: A Deep Dive into 2024 Financial Results In the recent strategic realignment, Prospera Energy Inc. (TSX.V: PEI, OTC: GXRFF) has successfully pivoted under new leadership, making significant strides in enhancing its production capabilities and financial outlook. This transformation was marked by key appointments, including Shubham Garg...

Continue Reading